Ajax-Loading

AbbVie Inc - Price To Tangible Book Ratio

AbbVie Inc's Fiscal Year is From January To December.

The item "Price-To-Tangible-Book-Ratio" stands at -6.63 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of AbbVie Inc's third quarter, the item "Price To Tangible Book Ratio" stands at -6.63. This represents a decrease of -21.70 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.26 compared to the value the year prior.
The Serie's long term average value is -5.21. It's latest available value, on 09/30/2025, is -1.43 lower, compared to it's long term average value.
The Serie's change from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0 .
The Serie's change from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -2.42 .

Price To Tangible Book Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Price To Tangible Book Ratio905,699,262,464.00
LogoJohnson & Johnson - Price To Tangible Book Ratio486,508,953,600.00
LogoRoche Holding AG - Price To Tangible Book Ratio317,433,206,677.55
LogoAstraZeneca PLC - Price To Tangible Book Ratio280,205,508,085.11
LogoNovartis AG - Price To Tangible Book Ratio255,096,620,580.91